Asahi Kasei Pharma
Corporate Profile
Asahi Kasei Pharma is the core operating company of the Asahi Kasei Group for pharmaceuticals, pharmaceutical intermediates, diagnostic reagents, nutritional products, and animal health products.
| Main businesses | Pharmaceuticals, pharmaceutical intermediates, feed additives, diagnostics |
|---|---|
| Home office | 1-105 Kanda Jinbocho, Chiyoda-ku, Tokyo 101-8101 Japan |
| President | Tsutomu Inada |
| Paid-in capital | 3,000 million yen |
| Shareholder | Asahi Kasei Corporation |
 |
| (as of April 1, 2009) |
| On October 1, 2008, ownership of Asahi Kasei Kuraray Medical and Asahi Kasei Medical was transferred from Asahi Kasei Pharma, a core operating company of the Asahi Kasei Group, to Asahi Kasei, holding company of the Asahi Kasei Group. |
Major Products
- Elcitonin™, Bredinin™, Flivas™, Toledomin™, and other pharmaceuticals
- Pharmaceutical intermediates, diagnostic reagents, feed additives
- Contact lenses
- Diagnostic reagents
Major Subsidiaries
| Asahi Pharma Spain, S.L | Pharmaceuticals | Spain | +34-93-588-6194 |
|---|---|---|---|
| Asahikasei Aime Co., Ltd. | Contact lenses | Japan | +81-(0)45-752-5928 |
Corporate Officers of Asahi Kasei Pharma
| Tsutomu Inada | President & Representative Director Presidential Executive Officer |
|---|---|
| Akio Kobayashi | Director Senior Executive Officer |
| Toshio Asano | Director Senior Executive Officer |
| Yasuyuki Yoshida | Director |
| Tadashi Nagatani | Executive Officer |
| Kazuyoshi Hori | Executive Officer |
| Gensho Takahashi | Corporate Auditor |
| Hiroki Ideguchi | Corporate Auditor |
|
| (as of June 26, 2009) |
